TrianglePUBLICATIONS · 22392565
Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer
- Publication date
- 2012 Oct 1
- First author
- Sorrell AD
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Sorrell AD
- type
- Author
- name
- Alonzo TA
- type
- Author
- name
- Hilden JM
- type
- Author
- name
- Gerbing RB
- type
- Author
- name
- Loew TW
- type
- Author
- name
- Hathaway L
- type
- Author
- name
- Barnard D
- type
- Author
- name
- Taub JW
- type
- Author
- name
- Ravindranath Y
- type
- Author
- name
- Smith FO
- type
- Author
- name
- Arceci RJ
- type
- Author
- name
- Woods WG
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Sorrell AD
- type
- Author
- name
- Alonzo TA
- type
- Author
- name
- Hilden JM
- type
- Author
- name
- Gerbing RB
- type
- Author
- name
- Loew TW
- type
- Author
- name
- Hathaway L
- type
- Author
- name
- Barnard D
- type
- Author
- name
- Taub JW
- type
- Author
- name
- Ravindranath Y
- type
- Author
- name
- Smith FO
- type
- Author
- name
- Arceci RJ
- type
- Author
- name
- Woods WG
- type
- Author
- bibliography ids
- nci-bib-1cec8d864018d4fba198d25d
- book metadata
- content sha256
- c8b363f513298203cf5808db66f3b048f6d26ecc0c265e11e7b2187eb7f59ecd
- document type
- citation
- dois
- 10.1002/cncr.27484
- electronic publication date
- display
- 2012 Mar 5
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22392565
- immutable id
- pubmed:22392565@c8b363f513298203cf5808db66f3b048f6d26ecc0c265e11e7b2187eb7f59ecd
- journal
- abbreviation
- Cancer
- issn electronic
- 1097-0142
- issn print
- 0008-543X
- issue
- 19
- name
- Cancer
- nlm unique id
- 0374236
- pages
- 4806-14
- volume
- 118
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 22392565
- provenance
- batch id
- b6284687e167e7da9556
- provider
- NCBI PubMed ESummary
- record sha256
- 649f624df1dfd7a8d0677af82687ca20dc5fe5cb434e54cc472222da97112d57
- response sha256
- 64d5b7bb63f574c559af2523b779a262267cbc8e8cd02a5b47f4193cc95cabd3
- retrieved at
- 2026-09-09T23:46:45.216259+00:00
- publication date
- display
- 2012 Oct 1
- precision
- day
- year
- 2012
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group.
Preserved source evidence · Not medical advice